Global Krabbe Disease Treatment Market 2022-2026

PUBLISHED: April 24, 2022

PAGES: 120 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Technavio has been monitoring the Krabbe disease treatment market and it is poised to grow by $ 438.03 mn during 2022-2026, accelerating at a CAGR of 7.56% during the forecast period. Our report on the Krabbe disease treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by special drug designation, unmet clinical needs, and the practice of consanguineous marriage.

The Krabbe disease treatment market analysis includes the therapy segment and geographic landscape.

Technavio's Krabbe disease treatment market is segmented as below:

By Therapy

Anticonvulsants
Muscle relaxants
HSCT
Others

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of pharmacological chaperone therapy as one of the prime reasons driving the Krabbe disease treatment market growth during the next few years. Also, gene technology in therapy and an increasing degree of awareness about Krabbe disease will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the Krabbe disease treatment market covers the following areas:

Krabbe disease treatment market sizing
Krabbe disease treatment market forecast
Krabbe disease treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Krabbe disease treatment market vendors that include AbbVie Inc., Acorda Therapeutics Inc., CENTOGENE NV, GlaxoSmithKline Plc, Johnson and Johnson, Novartis AG, Pfizer Inc., Polaryx, Teva Pharmaceutical Industries Ltd., and UCB SA. Also, the Krabbe disease treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73314

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Therapy

5.1 Market segments
Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
5.2 Comparison by Therapy
Exhibit 26: Chart on Comparison by Therapy
Exhibit 27: Data Table on Comparison by Therapy
5.3 Anticonvulsants - Market size and forecast 2021-2026
Exhibit 28: Chart on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Anticonvulsants - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Anticonvulsants - Year-over-year growth 2021-2026 (%)
5.4 Muscle relaxants - Market size and forecast 2021-2026
Exhibit 32: Chart on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Muscle relaxants - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Muscle relaxants - Year-over-year growth 2021-2026 (%)
5.5 HSCT - Market size and forecast 2021-2026
Exhibit 36: Chart on HSCT - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on HSCT - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on HSCT - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on HSCT - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Therapy
Exhibit 44: Market opportunity by Therapy ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share by geography 2021-2026 (%)
Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 China - Market size and forecast 2021-2026
Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity by geography
Exhibit 90: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 97: AbbVie Inc. - Overview
Exhibit 98: AbbVie Inc. - Product / Service
Exhibit 99: AbbVie Inc. - Key offerings
10.4 Acorda Therapeutics Inc.
Exhibit 100: Acorda Therapeutics Inc. - Overview
Exhibit 101: Acorda Therapeutics Inc. - Business segments
Exhibit 102: Acorda Therapeutics Inc. - Key offerings
Exhibit 103: Acorda Therapeutics Inc. - Segment focus
10.5 CENTOGENE NV
Exhibit 104: CENTOGENE NV - Overview
Exhibit 105: CENTOGENE NV - Key offerings
10.6 GlaxoSmithKline Plc
Exhibit 106: GlaxoSmithKline Plc - Overview
Exhibit 107: GlaxoSmithKline Plc - Business segments
Exhibit 108: GlaxoSmithKline Plc - Key news
Exhibit 109: GlaxoSmithKline Plc - Key offerings
Exhibit 110: GlaxoSmithKline Plc - Segment focus
10.7 Johnson and Johnson
Exhibit 111: Johnson and Johnson - Overview
Exhibit 112: Johnson and Johnson - Business segments
Exhibit 113: Johnson and Johnson - Key news
Exhibit 114: Johnson and Johnson - Key offerings
Exhibit 115: Johnson and Johnson - Segment focus
10.8 Novartis AG
Exhibit 116: Novartis AG - Overview
Exhibit 117: Novartis AG - Business segments
Exhibit 118: Novartis AG - Key offerings
Exhibit 119: Novartis AG - Segment focus
10.9 Pfizer Inc.
Exhibit 120: Pfizer Inc. - Overview
Exhibit 121: Pfizer Inc. - Product / Service
Exhibit 122: Pfizer Inc. - Key news
Exhibit 123: Pfizer Inc. - Key offerings
10.10 Polaryx
Exhibit 124: Polaryx - Overview
Exhibit 125: Polaryx - Product / Service
Exhibit 126: Polaryx - Key offerings
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 127: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 128: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 130: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 131: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 UCB SA
Exhibit 132: UCB SA - Overview
Exhibit 133: UCB SA - Product / Service
Exhibit 134: UCB SA - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 135: Inclusions checklist
Exhibit 136: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 137: Currency conversion rates for US$
11.4 Research methodology
Exhibit 138: Research methodology
Exhibit 139: Validation techniques employed for market sizing
Exhibit 140: Information sources
11.5 List of abbreviations
Exhibit 141: List of abbreviations

Product Code: IRTNTR73314

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapy
Exhibits27: Data Table on Comparison by Therapy
Exhibits28: Chart on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Anticonvulsants - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Anticonvulsants - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Anticonvulsants - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Muscle relaxants - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Muscle relaxants - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Muscle relaxants - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on HSCT - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on HSCT - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on HSCT - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on HSCT - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Therapy ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share by geography 2021-2026 (%)
Exhibits47: Data Table on Market share by geography 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity by geography ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: AbbVie Inc. - Overview
Exhibits98: AbbVie Inc. - Product / Service
Exhibits99: AbbVie Inc. - Key offerings
Exhibits100: Acorda Therapeutics Inc. - Overview
Exhibits101: Acorda Therapeutics Inc. - Business segments
Exhibits102: Acorda Therapeutics Inc. - Key offerings
Exhibits103: Acorda Therapeutics Inc. - Segment focus
Exhibits104: CENTOGENE NV - Overview
Exhibits105: CENTOGENE NV - Key offerings
Exhibits106: GlaxoSmithKline Plc - Overview
Exhibits107: GlaxoSmithKline Plc - Business segments
Exhibits108: GlaxoSmithKline Plc - Key news
Exhibits109: GlaxoSmithKline Plc - Key offerings
Exhibits110: GlaxoSmithKline Plc - Segment focus
Exhibits111: Johnson and Johnson - Overview
Exhibits112: Johnson and Johnson - Business segments
Exhibits113: Johnson and Johnson - Key news
Exhibits114: Johnson and Johnson - Key offerings
Exhibits115: Johnson and Johnson - Segment focus
Exhibits116: Novartis AG - Overview
Exhibits117: Novartis AG - Business segments
Exhibits118: Novartis AG - Key offerings
Exhibits119: Novartis AG - Segment focus
Exhibits120: Pfizer Inc. - Overview
Exhibits121: Pfizer Inc. - Product / Service
Exhibits122: Pfizer Inc. - Key news
Exhibits123: Pfizer Inc. - Key offerings
Exhibits124: Polaryx - Overview
Exhibits125: Polaryx - Product / Service
Exhibits126: Polaryx - Key offerings
Exhibits127: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits128: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits129: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits130: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits131: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits132: UCB SA - Overview
Exhibits133: UCB SA - Product / Service
Exhibits134: UCB SA - Key offerings
Exhibits135: Inclusions checklist
Exhibits136: Exclusions checklist
Exhibits137: Currency conversion rates for US$
Exhibits138: Research methodology
Exhibits139: Validation techniques employed for market sizing
Exhibits140: Information sources
Exhibits141: List of abbreviations